收藏切换
Brief analysis on the collaboration of drugs for rare diseases in China
收藏切换
PDF
Ying-hui YU1, Yun-feng LIAO2, Bin ZHOU1
Chinese Journal of New Drugs | 2023, 32(17) : 1707 - 1711
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(17): 1707-1711
Brief analysis on the collaboration of drugs for rare diseases in China
Full
Ying-hui YU1, Yun-feng LIAO2, Bin ZHOU1
Affiliations
  • 1China State Institute of Pharmaceutical Industry China National Pharmaceutical Industry Information Center, Shanghai 201203, China
  • 2Tasly Biopharmaceutical Company, Shanghai 201203, China
Published: 2023-09-15
Outline
收藏切换

The drug R&D of rare diseases in China is still in early stage. Collaborations have become a choice for many companies to enter that field. This article analyzes the collaboration deals involving Chinese companies from year 2011 to April 30th, 2022 on drugs with indication included in the first batch of rare disease list. It is found that as the country has put more emphasis on rare diseases, the number of transactions has increased significantly after the year of 2019. The deal model is mainly licensing deal, and transactions in rare disease indications with a big population is relatively concentrated. A group of biotechnology companies with rare diseases as their strategic focus have emerged. It is suggested to promote the legislation of rare diseases in China and more incentive policies concerning the research and development in rare diseases can be introduced in the future, so as to promote more Chinese companies to join in the research and development of innovative drugs in the rare diseases, and to further accelerate the development of local innovative drugs for rare diseases.

rare disease drugs  /  collaboration  /  company
Ying-hui YU, Yun-feng LIAO, Bin ZHOU. Brief analysis on the collaboration of drugs for rare diseases in China[J]. Chinese Journal of New Drugs, 2023 , 32 (17) : 1707 -1711 .
Year 2023 volume 32 Issue 17
PDF
34
16
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-09-15
Article Data
Affiliations
History
  • Accepted:2023-05-19
Affiliations
    1China State Institute of Pharmaceutical Industry China National Pharmaceutical Industry Information Center, Shanghai 201203, China
    2Tasly Biopharmaceutical Company, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT